Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Окт. 27, 2023
Tuberculosis
(TB)
remains
a
significant
global
health
challenge,
claiming
the
lives
of
up
to
1.5
million
individuals
annually.
TB
is
caused
by
human
pathogen
Nature Reviews Microbiology,
Год журнала:
2022,
Номер
20(11), С. 685 - 701
Опубликована: Апрель 27, 2022
Despite
two
decades
of
intensified
research
to
understand
and
cure
tuberculosis
disease,
biological
uncertainties
remain
hamper
progress.
However,
owing
collaborative
initiatives
including
academia,
the
pharmaceutical
industry
non-for-profit
organizations,
drug
candidate
pipeline
is
promising.
This
exceptional
success
comes
with
inherent
challenge
prioritizing
multidrug
regimens
for
clinical
trials
revamping
trial
designs
accelerate
regimen
development
capitalize
on
discovery
breakthroughs.
Most
wanted
are
markers
progression
from
latent
infection
active
pulmonary
response
predictors
relapse,
in
vitro
tools
uncover
synergies
that
translate
clinically
animal
models
reliably
assess
treatment
shortening
potential
new
regimens.
In
this
Review,
we
highlight
benefits
challenges
'one-size-fits-all'
duration
versus
individualized
therapy
based
disease
severity
host
pathogen
characteristics,
considering
scientific
operational
perspectives.
Nature Reviews Drug Discovery,
Год журнала:
2023,
Номер
22(6), С. 496 - 520
Опубликована: Апрель 28, 2023
Single-cell
technologies,
particularly
single-cell
RNA
sequencing
(scRNA-seq)
methods,
together
with
associated
computational
tools
and
the
growing
availability
of
public
data
resources,
are
transforming
drug
discovery
development.
New
opportunities
emerging
in
target
identification
owing
to
improved
disease
understanding
through
cell
subtyping,
highly
multiplexed
functional
genomics
screens
incorporating
scRNA-seq
enhancing
credentialling
prioritization.
ScRNA-seq
is
also
aiding
selection
relevant
preclinical
models
providing
new
insights
into
mechanisms
action.
In
clinical
development,
can
inform
decision-making
via
biomarker
for
patient
stratification
more
precise
monitoring
response
progression.
Here,
we
illustrate
how
methods
being
applied
key
steps
discuss
ongoing
challenges
their
implementation
pharmaceutical
industry.
There
have
been
significant
recent
advances
development
remarkable
Ferran
colleagues
primarily
pipeline,
from
decision-making.
Ongoing
potential
future
directions
discussed.
Nature Medicine,
Год журнала:
2023,
Номер
29(1), С. 258 - 269
Опубликована: Янв. 1, 2023
Abstract
Antigen-specific,
MHC-restricted
αβ
T
cells
are
necessary
for
protective
immunity
against
Mycobacterium
tuberculosis
,
but
the
ability
to
broadly
study
these
responses
has
been
limited.
In
present
study,
we
used
single-cell
and
bulk
cell
receptor
(TCR)
sequencing
GLIPH2
algorithm
analyze
M.
-specific
sequences
in
two
longitudinal
cohorts,
comprising
166
individuals
with
infection
who
progressed
either
(
n
=
48)
or
controlled
118).
We
found
24
groups
similar
TCR-β
sequences,
predicted
by
have
common
TCR
specificities,
which
were
associated
control
of
17),
others
that
progression
disease
7).
Using
a
genome-wide
antigen
screen,
identified
peptides
targeted
similarity
enriched
controllers
progressors.
propose
antigens
recognized
can
be
considered
as
high-priority
targets
future
vaccine
development.
Cell,
Год журнала:
2023,
Номер
186(25), С. 5536 - 5553.e22
Опубликована: Ноя. 28, 2023
Mycobacterium
tuberculosis
(Mtb)
causes
1.6
million
deaths
annually.
Active
correlates
with
a
neutrophil-driven
type
I
interferon
(IFN)
signature,
but
the
cellular
mechanisms
underlying
pathogenesis
remain
poorly
understood.
We
found
that
interstitial
macrophages
(IMs)
and
plasmacytoid
dendritic
cells
(pDCs)
are
dominant
producers
of
IFN
during
Mtb
infection
in
mice
non-human
primates,
pDCs
localize
near
human
granulomas.
Depletion
reduces
burdens,
implicating
pathogenesis.
During
IFN-driven
disease,
we
observe
abundant
DNA-containing
neutrophil
extracellular
traps
(NETs)
described
to
activate
pDCs.
Cell-type-specific
disruption
receptor
suggests
IFNs
act
on
IMs
inhibit
control.
Single-cell
RNA
sequencing
(scRNA-seq)
indicates
IFN-responsive
defective
their
response
IFNγ,
cytokine
critical
for
propose
pDC-derived
permit
bacterial
replication,
driving
further
recruitment
active
disease.
Journal of Clinical Investigation,
Год журнала:
2024,
Номер
134(1)
Опубликована: Янв. 1, 2024
Sarcoidosis
is
a
complex
immune-mediated
disease
characterized
by
clusters
of
immune
cells
called
granulomas.
Despite
major
steps
in
understanding
the
cause
this
disease,
many
questions
remain.
In
Review,
we
perform
mechanistic
interrogation
activities
that
contribute
to
granuloma
formation
sarcoidosis
and
compare
these
processes
with
its
closest
mimic,
tuberculosis,
highlighting
shared
divergent
activities.
We
examine
how
Mycobacterium
tuberculosis
sensed
system;
initiated,
formed,
perpetuated
compared
sarcoidosis;
role
innate
adaptive
shaping
processes.
Finally,
draw
findings
together
around
several
recent
high-resolution
studies
situ
utilized
latest
advances
single-cell
technology
combined
spatial
methods
analyze
plausible
mechanisms.
conclude
an
overall
view
sarcoidosis.
The Journal of Experimental Medicine,
Год журнала:
2025,
Номер
222(4)
Опубликована: Янв. 17, 2025
Tuberculosis
(TB)
is
a
major
health
burden
worldwide
despite
widespread
intradermal
(ID)
BCG
vaccination
in
newborns.
We
previously
demonstrated
that
changing
the
route
and
dose
from
5
×
105
CFUs
ID
to
107
i.v.
resulted
prevention
of
Mycobacterium
tuberculosis
(Mtb)
infection
TB
disease
highly
susceptible
nonhuman
primates.
Identifying
immune
mechanisms
protection
following
will
facilitate
development
more
effective
vaccines
against
TB.
Here,
we
depleted
lymphocyte
subsets
prior
during
Mtb
challenge
BCG-vaccinated
macaques
identify
those
necessary
for
protection.
Depletion
adaptive
CD4
T
cells,
but
not
CD8αβ
loss
with
increased
burdens
dissemination,
indicating
cells
are
critical
BCG-mediated
unconventional
CD8α-expressing
lymphocytes
(NK
innate
CD4+CD8α+
double-positive
cells)
abrogated
most
BCG-immunized
macaques,
supporting
further
investigation
into
which
these
cell
contribute
after
vaccination.
Intradermal
Bacillus
Calmette-Guérin
(BCG)
is
the
most
widely
administered
vaccine,
but
it
does
not
sufficiently
protect
adults
against
pulmonary
tuberculosis.
Recent
studies
in
nonhuman
primates
show
that
intravenous
BCG
administration
offers
superior
protection
Mycobacterium
tuberculosis
(
Mtb
).
We
used
single-cell
analysis
of
bronchoalveolar
lavage
cells
from
rhesus
macaques
vaccinated
via
different
routes
and
doses
to
identify
alterations
immune
ecosystem
airway
following
vaccination.
Our
findings
reveal
high-dose
induces
an
influx
polyfunctional
T
macrophages
airways,
with
alveolar
displaying
a
basal
activation
state
absence
purified
protein
derivative
stimulation,
defined
part
by
interferon
signaling.
Enhanced
intercellular
signaling
stronger
helper
1–T
17
transcriptional
responses
were
observed
stimulation.
These
results
suggest
vaccination
creates
specialized
environment
primes
for
effective
clearance.